Bevy of measures announced to speed up rare disease treatment

Rare disease drugs account for over half the first two batches of drugs eligible for a fast approval track targeting medications already approved overseas and in urgent need for Chinese patients.

AI industry booming in central China's Henan

ZHENGZHOU -- AI-related industries in Central China's Henan province have enjoyed a strong growth momentum, with a scale now exceeding 30 billion yuan ($4.5 billion), according to local authorities.

Johnson & Johnson pauses COVID-19 vaccine trial over patient illness

WASHINGTON - US pharmaceutical company Johnson & Johnson said Monday it had paused its COVID-19 vaccine trial because one of its participants had become sick.

Filling gaps in drug development

I-Mab Biopharma accelerates worldwide expansion through R&D, licensing deals

Demand for healthcare products booms on increasing awareness

COVID-19 has made people acutely conscious of good health, which is creating huge demand for products and services in the industry, experts said.

Old and new worlds collide with robot-brewed TCM coffee

Beijing Orion Star Technology Co, a service robot company backed by Cheetah Mobile, has inked an agreement with a healthcare service brand of Tongrentang to inject new vitality into the coffee sector.

Surgeon carries out remote operation using 5G technology

An ultra-remote surgery aided by 5G technology was completed in Qingdao, East China's Shandong province, on Sept 24, 2020.

Homemade vaccines set to rise in domestic market

In a first for Chinese drug-makers, Walvax Biotechnology Co Ltd has produced a vaccine branded Weuphoria that protects little children and infants from a variety of diseases like pneumonia, bacteremia, meningitis, otitis media and sinusitis.

HK tech products charm world amid pandemic

The coronavirus has catapulted Hong Kong's high-tech anti-pandemic products onto the world stage, while boosting e-payment among local consumers, says Secretary for Innovation and Technology Alfred Sit Wing-hang.

COVID-19 vaccine "Sputnik V" undergoing phase-3 clinical trials